These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Growth and differentiation advantages of CD4+ OX40+ T cells from allogeneic hematopoietic stem cell transplantation recipients. Shindo T; Ishikawa T; Fukunaga A; Hori T; Uchiyama T Biol Blood Marrow Transplant; 2008 Mar; 14(3):268-81. PubMed ID: 18275893 [TBL] [Abstract][Full Text] [Related]
4. The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement. Weinberg AD; Evans DE; Thalhofer C; Shi T; Prell RA J Leukoc Biol; 2004 Jun; 75(6):962-72. PubMed ID: 14996827 [TBL] [Abstract][Full Text] [Related]
5. Characterization of rat OX40 ligand by monoclonal antibody. Satake Y; Akiba H; Takeda K; Atsuta M; Yagita H; Okumura K Biochem Biophys Res Commun; 2000 Apr; 270(3):1041-8. PubMed ID: 10772947 [TBL] [Abstract][Full Text] [Related]
6. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines. Harrop JA; Reddy M; Dede K; Brigham-Burke M; Lyn S; Tan KB; Silverman C; Eichman C; DiPrinzio R; Spampanato J; Porter T; Holmes S; Young PR; Truneh A J Immunol; 1998 Aug; 161(4):1786-94. PubMed ID: 9712045 [TBL] [Abstract][Full Text] [Related]
7. Activated T cells express the OX40 ligand: requirements for induction and costimulatory function. Mendel I; Shevach EM Immunology; 2006 Feb; 117(2):196-204. PubMed ID: 16423055 [TBL] [Abstract][Full Text] [Related]
8. Endothelial cell co-stimulation through OX40 augments and prolongs T cell cytokine synthesis by stabilization of cytokine mRNA. Mestas J; Crampton SP; Hori T; Hughes CC Int Immunol; 2005 Jun; 17(6):737-47. PubMed ID: 15908450 [TBL] [Abstract][Full Text] [Related]
9. Expression and costimulatory effects of the TNF receptor superfamily members CD134 (OX40) and CD137 (4-1BB), and their role in the generation of anti-tumor immune responses. Taraban VY; Rowley TF; O'Brien L; Chan HT; Haswell LE; Green MH; Tutt AL; Glennie MJ; Al-Shamkhani A Eur J Immunol; 2002 Dec; 32(12):3617-27. PubMed ID: 12516549 [TBL] [Abstract][Full Text] [Related]
10. Anti-OX40 stimulation in vivo enhances CD8+ memory T cell survival and significantly increases recall responses. Ruby CE; Redmond WL; Haley D; Weinberg AD Eur J Immunol; 2007 Jan; 37(1):157-66. PubMed ID: 17183611 [TBL] [Abstract][Full Text] [Related]
11. gamma(c) cytokines provide multiple homeostatic signals to naive CD4(+) T cells. Masse GX; Corcuff E; Decaluwe H; Bommhardt U; Lantz O; Buer J; Di Santo JP Eur J Immunol; 2007 Sep; 37(9):2606-16. PubMed ID: 17683114 [TBL] [Abstract][Full Text] [Related]
12. OX40-mediated differentiation to effector function requires IL-2 receptor signaling but not CD28, CD40, IL-12Rbeta2, or T-bet. Williams CA; Murray SE; Weinberg AD; Parker DC J Immunol; 2007 Jun; 178(12):7694-702. PubMed ID: 17548606 [TBL] [Abstract][Full Text] [Related]
13. Cooperation between CD4 and CD8 T cells for anti-tumor activity is enhanced by OX40 signals. Song A; Song J; Tang X; Croft M Eur J Immunol; 2007 May; 37(5):1224-32. PubMed ID: 17429847 [TBL] [Abstract][Full Text] [Related]
14. Synthesis of several chemokines but few cytokines by primed uncommitted precursor CD4 T cells suggests that these cells recruit other immune cells without exerting direct effector functions. Yang L; Mosmann T Eur J Immunol; 2004 Jun; 34(6):1617-26. PubMed ID: 15162431 [TBL] [Abstract][Full Text] [Related]
15. A signal through OX40 (CD134) allows anergic, autoreactive T cells to acquire effector cell functions. Lathrop SK; Huddleston CA; Dullforce PA; Montfort MJ; Weinberg AD; Parker DC J Immunol; 2004 Jun; 172(11):6735-43. PubMed ID: 15153490 [TBL] [Abstract][Full Text] [Related]
16. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology. Ishii N; Takahashi T; Soroosh P; Sugamura K Adv Immunol; 2010; 105():63-98. PubMed ID: 20510730 [TBL] [Abstract][Full Text] [Related]
17. Availability of antigen-presenting cells can determine the extent of CD4 effector expansion and priming for secretion of Th2 cytokines in vivo. Bradley LM; Harbertson J; Biederman E; Zhang Y; Bradley SM; Linton PJ Eur J Immunol; 2002 Aug; 32(8):2338-46. PubMed ID: 12209647 [TBL] [Abstract][Full Text] [Related]
18. OX40 ligation enhances cell cycle turnover of Ag-activated CD4 T cells in vivo. Weatherill AR; Maxwell JR; Takahashi C; Weinberg AD; Vella AT Cell Immunol; 2001 Apr; 209(1):63-75. PubMed ID: 11414737 [TBL] [Abstract][Full Text] [Related]
19. High levels of human antigen-specific CD4+ T cells in peripheral blood revealed by stimulated coexpression of CD25 and CD134 (OX40). Zaunders JJ; Munier ML; Seddiki N; Pett S; Ip S; Bailey M; Xu Y; Brown K; Dyer WB; Kim M; de Rose R; Kent SJ; Jiang L; Breit SN; Emery S; Cunningham AL; Cooper DA; Kelleher AD J Immunol; 2009 Aug; 183(4):2827-36. PubMed ID: 19635903 [TBL] [Abstract][Full Text] [Related]
20. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity. Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]